默沙东在第八届进博会展示丰富在研管线

Core Insights - Merck has showcased its commitment to innovation and collaboration in the healthcare sector at the 8th China International Import Expo, emphasizing its theme of "Innovative Science, Healthy Future" [1] Group 1: Product and Pipeline Highlights - Merck is displaying approximately 30 approved drugs and vaccines in China, covering areas such as oncology, anti-infection, diabetes, and rare diseases, including several innovative drugs making their debut at the expo [1] - The company plans to introduce over 40 new products and indications to China in the next five years, with ongoing clinical research in multiple therapeutic areas [1] Group 2: Collaborations and Initiatives - Over the past three years, Merck has engaged in several R&D collaborations with five local pharmaceutical companies, focusing on cardiovascular, metabolic, and oncology fields [1] - The establishment of the Merck China Innovation Collaboration Center (MCICC) on November 1, 2024, aims to enhance cooperation with China's life sciences innovation ecosystem, promoting rapid and high-quality clinical translation of breakthrough innovations from China [1] Group 3: Animal Health Segment - In the animal health sector, Merck will showcase products and solutions covering five major business areas: pets, poultry, pigs, ruminants, and aquaculture [2] - The company will also host several thematic events focusing on key areas such as oncology, rare diseases, and public health [2]